Global Drug Eluting Stents Market

Drug Eluting Stents Comprehensive Study by Type (Bare metal Stents, Drug eluting Stents, Drug eluting Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease), Drug Coating (Polymer-based Coatings, Polymer free Coatings), End user (Hospitals, Clinics, Other) Players and Region - Global Market Outlook to 2028

Drug Eluting Stents Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A drug-eluting stent is small expandable tubes made of wire placed into narrowed, diseased coronary arteries that slowly release a drug to block cell proliferation. Stent helps to hold the artery open to release a drug that stops blockage occurring in artery and increases the blood flow. The stent is generally placed within the coronary artery by an Interventional Cardiologist during an angioplasty procedure. The constantly rising geriatric population across the globe is primarily driving the growth of the market

The Global Drug Eluting Stents market presents a comprehensive analysis of the Drug Eluting Stents market by product type (Bare metal Stents, Drug eluting Stents and Drug eluting Balloons), by end-user/application (Coronary Artery Disease and Peripheral Artery Disease), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. The key Players profiled in the report are Abbott Laboratories (United States), Boston Scientific Corporation (United States), Terumo Corporation (Japan), Medtronic (Ireland), Biosensors International (Singapore), Cook Medical (United States), Envision Scientific (India) and Biotronik (Germany). Additionally, other players that are part of this comprehensive study are Lepu Medical (China) and Stentsys (France).

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Key Companies ProfiledAbbott Laboratories (United States), Boston Scientific Corporation (United States), Terumo Corporation (Japan), Medtronic (Ireland), Biosensors International (Singapore), Cook Medical (United States), Envision Scientific (India) and Biotronik (Germany)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
The reimbursement coverage along with a high incidence rate of artery diseases

Market Growth Drivers:
The rising geriatric population worldwide and The increasing prevalence of chronic diseases, such as diabetes and cardiac arrest

Challenges:
Decreasing price of device.

Restraints:
Rising risk of developing late-stage thrombosis

Opportunities:
Increasing demand from emerging economies

Regional Breakdown and Segment Analysis
This section of our report presents a realistic picture of the Global Drug Eluting Stents industry. Investors and manufacturers can easily understand the inherent opportunities and challenges for their products in the geographical region of interest. For instance, while the North America holds majority of market share of the Drug Eluting Stents, the Asia Pacific has emerged as a crucial market for several Drug Eluting Stents brands.

The Drug Coating, such as Polymer-based Coatings, is boosting the Drug Eluting Stents market and is anticipated to experience a steady growth during the forecast period.

The End user, such as Hospitals, is boosting the Drug Eluting Stents market and is anticipated to experience a steady growth during the forecast period.

On 24 Sept, 2018, Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia™ Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD)
The regional segmentation covered in this report are:
South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)

Report Objectives / Segmentation Covered

By Type
  • Bare metal Stents
  • Drug eluting Stents
  • Drug eluting Balloons
By Application
  • Coronary Artery Disease
  • Peripheral Artery Disease
By Drug Coating
  • Polymer-based Coatings
  • Polymer free Coatings

By End user
  • Hospitals
  • Clinics
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rising geriatric population worldwide
      • 3.2.2. The increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
    • 3.3. Market Challenges
      • 3.3.1. Decreasing price of device.
    • 3.4. Market Trends
      • 3.4.1. The reimbursement coverage along with a high incidence rate of artery diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Eluting Stents, by Type, Application, Drug Coating, End user and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Eluting Stents (Value)
      • 5.2.1. Global Drug Eluting Stents by: Type (Value)
        • 5.2.1.1. Bare metal Stents
        • 5.2.1.2. Drug eluting Stents
        • 5.2.1.3. Drug eluting Balloons
      • 5.2.2. Global Drug Eluting Stents by: Application (Value)
        • 5.2.2.1. Coronary Artery Disease
        • 5.2.2.2. Peripheral Artery Disease
      • 5.2.3. Global Drug Eluting Stents by: Drug Coating (Value)
        • 5.2.3.1. Polymer-based Coatings
        • 5.2.3.2. Polymer free Coatings
      • 5.2.4. Global Drug Eluting Stents by: End user (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Other
      • 5.2.5. Global Drug Eluting Stents Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Drug Eluting Stents (Volume)
      • 5.3.1. Global Drug Eluting Stents by: Type (Volume)
        • 5.3.1.1. Bare metal Stents
        • 5.3.1.2. Drug eluting Stents
        • 5.3.1.3. Drug eluting Balloons
      • 5.3.2. Global Drug Eluting Stents by: Application (Volume)
        • 5.3.2.1. Coronary Artery Disease
        • 5.3.2.2. Peripheral Artery Disease
      • 5.3.3. Global Drug Eluting Stents by: Drug Coating (Volume)
        • 5.3.3.1. Polymer-based Coatings
        • 5.3.3.2. Polymer free Coatings
      • 5.3.4. Global Drug Eluting Stents by: End user (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Clinics
        • 5.3.4.3. Other
      • 5.3.5. Global Drug Eluting Stents Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Drug Eluting Stents (Price)
      • 5.4.1. Global Drug Eluting Stents by: Type (Price)
  • 6. Drug Eluting Stents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Terumo Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biosensors International (Singapore)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cook Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Envision Scientific (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biotronik (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Drug Eluting Stents Sale, by Type, Application, Drug Coating, End user and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Eluting Stents (Value)
      • 7.2.1. Global Drug Eluting Stents by: Type (Value)
        • 7.2.1.1. Bare metal Stents
        • 7.2.1.2. Drug eluting Stents
        • 7.2.1.3. Drug eluting Balloons
      • 7.2.2. Global Drug Eluting Stents by: Application (Value)
        • 7.2.2.1. Coronary Artery Disease
        • 7.2.2.2. Peripheral Artery Disease
      • 7.2.3. Global Drug Eluting Stents by: Drug Coating (Value)
        • 7.2.3.1. Polymer-based Coatings
        • 7.2.3.2. Polymer free Coatings
      • 7.2.4. Global Drug Eluting Stents by: End user (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Other
      • 7.2.5. Global Drug Eluting Stents Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Drug Eluting Stents (Volume)
      • 7.3.1. Global Drug Eluting Stents by: Type (Volume)
        • 7.3.1.1. Bare metal Stents
        • 7.3.1.2. Drug eluting Stents
        • 7.3.1.3. Drug eluting Balloons
      • 7.3.2. Global Drug Eluting Stents by: Application (Volume)
        • 7.3.2.1. Coronary Artery Disease
        • 7.3.2.2. Peripheral Artery Disease
      • 7.3.3. Global Drug Eluting Stents by: Drug Coating (Volume)
        • 7.3.3.1. Polymer-based Coatings
        • 7.3.3.2. Polymer free Coatings
      • 7.3.4. Global Drug Eluting Stents by: End user (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Clinics
        • 7.3.4.3. Other
      • 7.3.5. Global Drug Eluting Stents Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Drug Eluting Stents (Price)
      • 7.4.1. Global Drug Eluting Stents by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Eluting Stents: by Type(USD Million)
  • Table 2. Drug Eluting Stents Bare metal Stents , by Region USD Million (2017-2022)
  • Table 3. Drug Eluting Stents Drug eluting Stents , by Region USD Million (2017-2022)
  • Table 4. Drug Eluting Stents Drug eluting Balloons , by Region USD Million (2017-2022)
  • Table 5. Drug Eluting Stents: by Application(USD Million)
  • Table 6. Drug Eluting Stents Coronary Artery Disease , by Region USD Million (2017-2022)
  • Table 7. Drug Eluting Stents Peripheral Artery Disease , by Region USD Million (2017-2022)
  • Table 8. Drug Eluting Stents: by Drug Coating(USD Million)
  • Table 9. Drug Eluting Stents Polymer-based Coatings , by Region USD Million (2017-2022)
  • Table 10. Drug Eluting Stents Polymer free Coatings , by Region USD Million (2017-2022)
  • Table 11. Drug Eluting Stents: by End user(USD Million)
  • Table 12. Drug Eluting Stents Hospitals , by Region USD Million (2017-2022)
  • Table 13. Drug Eluting Stents Clinics , by Region USD Million (2017-2022)
  • Table 14. Drug Eluting Stents Other , by Region USD Million (2017-2022)
  • Table 15. South America Drug Eluting Stents, by Country USD Million (2017-2022)
  • Table 16. South America Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 17. South America Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 18. South America Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 19. South America Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 20. Brazil Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 21. Brazil Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 22. Brazil Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 23. Brazil Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 24. Argentina Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 25. Argentina Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 26. Argentina Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 27. Argentina Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 28. Rest of South America Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 29. Rest of South America Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 30. Rest of South America Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 31. Rest of South America Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 32. Asia Pacific Drug Eluting Stents, by Country USD Million (2017-2022)
  • Table 33. Asia Pacific Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 34. Asia Pacific Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 35. Asia Pacific Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 36. Asia Pacific Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 37. China Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 38. China Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 39. China Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 40. China Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 41. Japan Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 42. Japan Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 43. Japan Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 44. Japan Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 45. India Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 46. India Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 47. India Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 48. India Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 49. South Korea Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 50. South Korea Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 51. South Korea Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 52. South Korea Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 53. Taiwan Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 54. Taiwan Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 55. Taiwan Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 56. Taiwan Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 57. Australia Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 58. Australia Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 59. Australia Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 60. Australia Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 65. Europe Drug Eluting Stents, by Country USD Million (2017-2022)
  • Table 66. Europe Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 67. Europe Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 68. Europe Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 69. Europe Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 70. Germany Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 71. Germany Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 72. Germany Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 73. Germany Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 74. France Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 75. France Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 76. France Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 77. France Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 78. Italy Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 79. Italy Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 80. Italy Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 81. Italy Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 82. United Kingdom Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 83. United Kingdom Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 84. United Kingdom Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 85. United Kingdom Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 86. Netherlands Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 87. Netherlands Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 88. Netherlands Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 89. Netherlands Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 90. Rest of Europe Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 91. Rest of Europe Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 92. Rest of Europe Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 93. Rest of Europe Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 94. MEA Drug Eluting Stents, by Country USD Million (2017-2022)
  • Table 95. MEA Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 96. MEA Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 97. MEA Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 98. MEA Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 99. Middle East Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 100. Middle East Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 101. Middle East Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 102. Middle East Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 103. Africa Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 104. Africa Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 105. Africa Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 106. Africa Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 107. North America Drug Eluting Stents, by Country USD Million (2017-2022)
  • Table 108. North America Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 109. North America Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 110. North America Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 111. North America Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 112. United States Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 113. United States Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 114. United States Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 115. United States Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 116. Canada Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 117. Canada Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 118. Canada Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 119. Canada Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 120. Mexico Drug Eluting Stents, by Type USD Million (2017-2022)
  • Table 121. Mexico Drug Eluting Stents, by Application USD Million (2017-2022)
  • Table 122. Mexico Drug Eluting Stents, by Drug Coating USD Million (2017-2022)
  • Table 123. Mexico Drug Eluting Stents, by End user USD Million (2017-2022)
  • Table 124. Drug Eluting Stents Sales: by Type(K Units)
  • Table 125. Drug Eluting Stents Sales Bare metal Stents , by Region K Units (2017-2022)
  • Table 126. Drug Eluting Stents Sales Drug eluting Stents , by Region K Units (2017-2022)
  • Table 127. Drug Eluting Stents Sales Drug eluting Balloons , by Region K Units (2017-2022)
  • Table 128. Drug Eluting Stents Sales: by Application(K Units)
  • Table 129. Drug Eluting Stents Sales Coronary Artery Disease , by Region K Units (2017-2022)
  • Table 130. Drug Eluting Stents Sales Peripheral Artery Disease , by Region K Units (2017-2022)
  • Table 131. Drug Eluting Stents Sales: by Drug Coating(K Units)
  • Table 132. Drug Eluting Stents Sales Polymer-based Coatings , by Region K Units (2017-2022)
  • Table 133. Drug Eluting Stents Sales Polymer free Coatings , by Region K Units (2017-2022)
  • Table 134. Drug Eluting Stents Sales: by End user(K Units)
  • Table 135. Drug Eluting Stents Sales Hospitals , by Region K Units (2017-2022)
  • Table 136. Drug Eluting Stents Sales Clinics , by Region K Units (2017-2022)
  • Table 137. Drug Eluting Stents Sales Other , by Region K Units (2017-2022)
  • Table 138. South America Drug Eluting Stents Sales, by Country K Units (2017-2022)
  • Table 139. South America Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 140. South America Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 141. South America Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 142. South America Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 143. Brazil Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 144. Brazil Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 145. Brazil Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 146. Brazil Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 147. Argentina Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 148. Argentina Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 149. Argentina Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 150. Argentina Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 151. Rest of South America Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 152. Rest of South America Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 153. Rest of South America Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 154. Rest of South America Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 155. Asia Pacific Drug Eluting Stents Sales, by Country K Units (2017-2022)
  • Table 156. Asia Pacific Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 157. Asia Pacific Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 158. Asia Pacific Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 159. Asia Pacific Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 160. China Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 161. China Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 162. China Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 163. China Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 164. Japan Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 165. Japan Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 166. Japan Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 167. Japan Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 168. India Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 169. India Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 170. India Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 171. India Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 172. South Korea Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 173. South Korea Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 174. South Korea Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 175. South Korea Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 176. Taiwan Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 177. Taiwan Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 178. Taiwan Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 179. Taiwan Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 180. Australia Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 181. Australia Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 182. Australia Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 183. Australia Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 184. Rest of Asia-Pacific Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 185. Rest of Asia-Pacific Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 186. Rest of Asia-Pacific Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 187. Rest of Asia-Pacific Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 188. Europe Drug Eluting Stents Sales, by Country K Units (2017-2022)
  • Table 189. Europe Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 190. Europe Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 191. Europe Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 192. Europe Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 193. Germany Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 194. Germany Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 195. Germany Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 196. Germany Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 197. France Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 198. France Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 199. France Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 200. France Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 201. Italy Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 202. Italy Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 203. Italy Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 204. Italy Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 205. United Kingdom Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 206. United Kingdom Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 207. United Kingdom Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 208. United Kingdom Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 209. Netherlands Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 210. Netherlands Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 211. Netherlands Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 212. Netherlands Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 213. Rest of Europe Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 214. Rest of Europe Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 215. Rest of Europe Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 216. Rest of Europe Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 217. MEA Drug Eluting Stents Sales, by Country K Units (2017-2022)
  • Table 218. MEA Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 219. MEA Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 220. MEA Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 221. MEA Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 222. Middle East Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 223. Middle East Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 224. Middle East Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 225. Middle East Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 226. Africa Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 227. Africa Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 228. Africa Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 229. Africa Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 230. North America Drug Eluting Stents Sales, by Country K Units (2017-2022)
  • Table 231. North America Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 232. North America Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 233. North America Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 234. North America Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 235. United States Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 236. United States Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 237. United States Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 238. United States Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 239. Canada Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 240. Canada Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 241. Canada Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 242. Canada Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 243. Mexico Drug Eluting Stents Sales, by Type K Units (2017-2022)
  • Table 244. Mexico Drug Eluting Stents Sales, by Application K Units (2017-2022)
  • Table 245. Mexico Drug Eluting Stents Sales, by Drug Coating K Units (2017-2022)
  • Table 246. Mexico Drug Eluting Stents Sales, by End user K Units (2017-2022)
  • Table 247. Drug Eluting Stents: by Type(USD/Units)
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Drug Eluting Stents: by Type(USD Million)
  • Table 257. Drug Eluting Stents Bare metal Stents , by Region USD Million (2023-2028)
  • Table 258. Drug Eluting Stents Drug eluting Stents , by Region USD Million (2023-2028)
  • Table 259. Drug Eluting Stents Drug eluting Balloons , by Region USD Million (2023-2028)
  • Table 260. Drug Eluting Stents: by Application(USD Million)
  • Table 261. Drug Eluting Stents Coronary Artery Disease , by Region USD Million (2023-2028)
  • Table 262. Drug Eluting Stents Peripheral Artery Disease , by Region USD Million (2023-2028)
  • Table 263. Drug Eluting Stents: by Drug Coating(USD Million)
  • Table 264. Drug Eluting Stents Polymer-based Coatings , by Region USD Million (2023-2028)
  • Table 265. Drug Eluting Stents Polymer free Coatings , by Region USD Million (2023-2028)
  • Table 266. Drug Eluting Stents: by End user(USD Million)
  • Table 267. Drug Eluting Stents Hospitals , by Region USD Million (2023-2028)
  • Table 268. Drug Eluting Stents Clinics , by Region USD Million (2023-2028)
  • Table 269. Drug Eluting Stents Other , by Region USD Million (2023-2028)
  • Table 270. South America Drug Eluting Stents, by Country USD Million (2023-2028)
  • Table 271. South America Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 272. South America Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 273. South America Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 274. South America Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 275. Brazil Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 276. Brazil Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 277. Brazil Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 278. Brazil Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 279. Argentina Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 280. Argentina Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 281. Argentina Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 282. Argentina Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 283. Rest of South America Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 284. Rest of South America Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 285. Rest of South America Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 286. Rest of South America Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 287. Asia Pacific Drug Eluting Stents, by Country USD Million (2023-2028)
  • Table 288. Asia Pacific Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 289. Asia Pacific Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 290. Asia Pacific Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 291. Asia Pacific Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 292. China Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 293. China Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 294. China Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 295. China Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 296. Japan Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 297. Japan Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 298. Japan Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 299. Japan Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 300. India Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 301. India Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 302. India Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 303. India Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 304. South Korea Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 305. South Korea Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 306. South Korea Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 307. South Korea Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 308. Taiwan Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 309. Taiwan Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 310. Taiwan Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 311. Taiwan Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 312. Australia Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 313. Australia Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 314. Australia Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 315. Australia Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 316. Rest of Asia-Pacific Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 317. Rest of Asia-Pacific Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 318. Rest of Asia-Pacific Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 319. Rest of Asia-Pacific Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 320. Europe Drug Eluting Stents, by Country USD Million (2023-2028)
  • Table 321. Europe Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 322. Europe Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 323. Europe Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 324. Europe Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 325. Germany Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 326. Germany Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 327. Germany Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 328. Germany Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 329. France Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 330. France Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 331. France Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 332. France Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 333. Italy Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 334. Italy Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 335. Italy Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 336. Italy Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 337. United Kingdom Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 338. United Kingdom Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 339. United Kingdom Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 340. United Kingdom Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 341. Netherlands Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 342. Netherlands Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 343. Netherlands Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 344. Netherlands Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 345. Rest of Europe Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 346. Rest of Europe Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 347. Rest of Europe Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 348. Rest of Europe Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 349. MEA Drug Eluting Stents, by Country USD Million (2023-2028)
  • Table 350. MEA Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 351. MEA Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 352. MEA Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 353. MEA Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 354. Middle East Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 355. Middle East Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 356. Middle East Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 357. Middle East Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 358. Africa Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 359. Africa Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 360. Africa Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 361. Africa Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 362. North America Drug Eluting Stents, by Country USD Million (2023-2028)
  • Table 363. North America Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 364. North America Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 365. North America Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 366. North America Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 367. United States Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 368. United States Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 369. United States Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 370. United States Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 371. Canada Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 372. Canada Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 373. Canada Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 374. Canada Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 375. Mexico Drug Eluting Stents, by Type USD Million (2023-2028)
  • Table 376. Mexico Drug Eluting Stents, by Application USD Million (2023-2028)
  • Table 377. Mexico Drug Eluting Stents, by Drug Coating USD Million (2023-2028)
  • Table 378. Mexico Drug Eluting Stents, by End user USD Million (2023-2028)
  • Table 379. Drug Eluting Stents Sales: by Type(K Units)
  • Table 380. Drug Eluting Stents Sales Bare metal Stents , by Region K Units (2023-2028)
  • Table 381. Drug Eluting Stents Sales Drug eluting Stents , by Region K Units (2023-2028)
  • Table 382. Drug Eluting Stents Sales Drug eluting Balloons , by Region K Units (2023-2028)
  • Table 383. Drug Eluting Stents Sales: by Application(K Units)
  • Table 384. Drug Eluting Stents Sales Coronary Artery Disease , by Region K Units (2023-2028)
  • Table 385. Drug Eluting Stents Sales Peripheral Artery Disease , by Region K Units (2023-2028)
  • Table 386. Drug Eluting Stents Sales: by Drug Coating(K Units)
  • Table 387. Drug Eluting Stents Sales Polymer-based Coatings , by Region K Units (2023-2028)
  • Table 388. Drug Eluting Stents Sales Polymer free Coatings , by Region K Units (2023-2028)
  • Table 389. Drug Eluting Stents Sales: by End user(K Units)
  • Table 390. Drug Eluting Stents Sales Hospitals , by Region K Units (2023-2028)
  • Table 391. Drug Eluting Stents Sales Clinics , by Region K Units (2023-2028)
  • Table 392. Drug Eluting Stents Sales Other , by Region K Units (2023-2028)
  • Table 393. South America Drug Eluting Stents Sales, by Country K Units (2023-2028)
  • Table 394. South America Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 395. South America Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 396. South America Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 397. South America Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 398. Brazil Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 399. Brazil Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 400. Brazil Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 401. Brazil Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 402. Argentina Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 403. Argentina Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 404. Argentina Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 405. Argentina Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 406. Rest of South America Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 407. Rest of South America Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 408. Rest of South America Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 409. Rest of South America Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 410. Asia Pacific Drug Eluting Stents Sales, by Country K Units (2023-2028)
  • Table 411. Asia Pacific Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 412. Asia Pacific Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 413. Asia Pacific Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 414. Asia Pacific Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 415. China Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 416. China Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 417. China Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 418. China Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 419. Japan Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 420. Japan Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 421. Japan Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 422. Japan Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 423. India Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 424. India Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 425. India Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 426. India Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 427. South Korea Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 428. South Korea Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 429. South Korea Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 430. South Korea Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 431. Taiwan Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 432. Taiwan Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 433. Taiwan Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 434. Taiwan Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 435. Australia Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 436. Australia Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 437. Australia Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 438. Australia Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 439. Rest of Asia-Pacific Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 440. Rest of Asia-Pacific Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 441. Rest of Asia-Pacific Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 442. Rest of Asia-Pacific Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 443. Europe Drug Eluting Stents Sales, by Country K Units (2023-2028)
  • Table 444. Europe Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 445. Europe Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 446. Europe Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 447. Europe Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 448. Germany Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 449. Germany Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 450. Germany Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 451. Germany Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 452. France Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 453. France Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 454. France Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 455. France Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 456. Italy Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 457. Italy Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 458. Italy Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 459. Italy Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 460. United Kingdom Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 461. United Kingdom Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 462. United Kingdom Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 463. United Kingdom Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 464. Netherlands Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 465. Netherlands Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 466. Netherlands Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 467. Netherlands Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 468. Rest of Europe Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 469. Rest of Europe Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 470. Rest of Europe Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 471. Rest of Europe Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 472. MEA Drug Eluting Stents Sales, by Country K Units (2023-2028)
  • Table 473. MEA Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 474. MEA Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 475. MEA Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 476. MEA Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 477. Middle East Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 478. Middle East Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 479. Middle East Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 480. Middle East Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 481. Africa Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 482. Africa Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 483. Africa Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 484. Africa Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 485. North America Drug Eluting Stents Sales, by Country K Units (2023-2028)
  • Table 486. North America Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 487. North America Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 488. North America Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 489. North America Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 490. United States Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 491. United States Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 492. United States Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 493. United States Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 494. Canada Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 495. Canada Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 496. Canada Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 497. Canada Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 498. Mexico Drug Eluting Stents Sales, by Type K Units (2023-2028)
  • Table 499. Mexico Drug Eluting Stents Sales, by Application K Units (2023-2028)
  • Table 500. Mexico Drug Eluting Stents Sales, by Drug Coating K Units (2023-2028)
  • Table 501. Mexico Drug Eluting Stents Sales, by End user K Units (2023-2028)
  • Table 502. Drug Eluting Stents: by Type(USD/Units)
  • Table 503. Research Programs/Design for This Report
  • Table 504. Key Data Information from Secondary Sources
  • Table 505. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Eluting Stents: by Type USD Million (2017-2022)
  • Figure 5. Global Drug Eluting Stents: by Application USD Million (2017-2022)
  • Figure 6. Global Drug Eluting Stents: by Drug Coating USD Million (2017-2022)
  • Figure 7. Global Drug Eluting Stents: by End user USD Million (2017-2022)
  • Figure 8. South America Drug Eluting Stents Share (%), by Country
  • Figure 9. Asia Pacific Drug Eluting Stents Share (%), by Country
  • Figure 10. Europe Drug Eluting Stents Share (%), by Country
  • Figure 11. MEA Drug Eluting Stents Share (%), by Country
  • Figure 12. North America Drug Eluting Stents Share (%), by Country
  • Figure 13. Global Drug Eluting Stents: by Type K Units (2017-2022)
  • Figure 14. Global Drug Eluting Stents: by Application K Units (2017-2022)
  • Figure 15. Global Drug Eluting Stents: by Drug Coating K Units (2017-2022)
  • Figure 16. Global Drug Eluting Stents: by End user K Units (2017-2022)
  • Figure 17. South America Drug Eluting Stents Share (%), by Country
  • Figure 18. Asia Pacific Drug Eluting Stents Share (%), by Country
  • Figure 19. Europe Drug Eluting Stents Share (%), by Country
  • Figure 20. MEA Drug Eluting Stents Share (%), by Country
  • Figure 21. North America Drug Eluting Stents Share (%), by Country
  • Figure 22. Global Drug Eluting Stents: by Type USD/Units (2017-2022)
  • Figure 23. Global Drug Eluting Stents share by Players 2022 (%)
  • Figure 24. Global Drug Eluting Stents share by Players (Top 3) 2022(%)
  • Figure 25. Global Drug Eluting Stents share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 29. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 31. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Terumo Corporation (Japan) Revenue: by Geography 2022
  • Figure 33. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 35. Biosensors International (Singapore) Revenue, Net Income and Gross profit
  • Figure 36. Biosensors International (Singapore) Revenue: by Geography 2022
  • Figure 37. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cook Medical (United States) Revenue: by Geography 2022
  • Figure 39. Envision Scientific (India) Revenue, Net Income and Gross profit
  • Figure 40. Envision Scientific (India) Revenue: by Geography 2022
  • Figure 41. Biotronik (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Biotronik (Germany) Revenue: by Geography 2022
  • Figure 43. Global Drug Eluting Stents: by Type USD Million (2023-2028)
  • Figure 44. Global Drug Eluting Stents: by Application USD Million (2023-2028)
  • Figure 45. Global Drug Eluting Stents: by Drug Coating USD Million (2023-2028)
  • Figure 46. Global Drug Eluting Stents: by End user USD Million (2023-2028)
  • Figure 47. South America Drug Eluting Stents Share (%), by Country
  • Figure 48. Asia Pacific Drug Eluting Stents Share (%), by Country
  • Figure 49. Europe Drug Eluting Stents Share (%), by Country
  • Figure 50. MEA Drug Eluting Stents Share (%), by Country
  • Figure 51. North America Drug Eluting Stents Share (%), by Country
  • Figure 52. Global Drug Eluting Stents: by Type K Units (2023-2028)
  • Figure 53. Global Drug Eluting Stents: by Application K Units (2023-2028)
  • Figure 54. Global Drug Eluting Stents: by Drug Coating K Units (2023-2028)
  • Figure 55. Global Drug Eluting Stents: by End user K Units (2023-2028)
  • Figure 56. South America Drug Eluting Stents Share (%), by Country
  • Figure 57. Asia Pacific Drug Eluting Stents Share (%), by Country
  • Figure 58. Europe Drug Eluting Stents Share (%), by Country
  • Figure 59. MEA Drug Eluting Stents Share (%), by Country
  • Figure 60. North America Drug Eluting Stents Share (%), by Country
  • Figure 61. Global Drug Eluting Stents: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • Terumo Corporation (Japan)
  • Medtronic (Ireland)
  • Biosensors International (Singapore)
  • Cook Medical (United States)
  • Envision Scientific (India)
  • Biotronik (Germany)
Additional players considered in the study are as follows:
Lepu Medical (China) , Stentsys (France)
Select User Access Type

Key Highlights of Report


Dec 2023 214 Pages 69 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Eluting Stents Market Quantitative research analysis
Global Drug Eluting Stents Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Drug Eluting Stents market is predicted to grow at a CAGR of % between 2022 - 2028.
Global Drug Eluting Stents market is restrained by Rising risk of developing late-stage thrombosis.
Coronary Artery Disease is dominating end use application in Drug Eluting Stents Market.
The Drug Eluting Stents market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.

Know More About Global Drug Eluting Stents Market Report?

Have a Query? Click Here

Other Related Reports

RSV Diagnostics Comprehensive Study by Type (Kits and Assays, Instruments, Other Products), Application (Detection of RSV, Prevention RSV), End-User (Hospitals and Clinics, Clinical Laboratories, Hom...
$ 3750
Dental CAM Milling Machines Comprehensive Study by Type (4-axis machines, 5-axis machines), Application (Crowns, Dentures, Bridges, Veneers, Inlays & Onlays), Size (Benchtop, Tabletop, Standalone), M...
$ 3800
Peak Flow Meter Comprehensive Study by Type (Mechanical, Digital), Application (Peak Expiratory Flow Measurement, Forced Expiratory Volume Measurement), Sales (Direct Sales, Indirect Sales), End Use ...
$ 3450
Picture Archiving And Communication Systems Comprehensive Study by Component (Computed tomography, Magnetic resonance imaging, Others), End-use (Clinic, Hospitals, Others) Players and Region - Global...
$ 3500
Bioresorbable Scaffolds Comprehensive Study by Type (Synthetic, Biological), Application (Coronary Artery Stents, Peripheral Artery Stents, Others), Material (Metal-based Bioresorbable Scaffold, Poly...
$ 3650
Blood Transfusion Devices Comprehensive Study by Type (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), Application (Blood Disorders, Autoimmune Disorders,...
$ 3650